A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The primary objective of this study is to evaluate the long-term safety of Dorzagliatin in a larger population of type 2 diabetes mellitus patients by collecting the post-marketing clinical safety data of Dorzagliatin.
Epistemonikos ID: 2de0f2cd43b09b37032c5ef69629623ebee6beef
First added on: May 15, 2024